|Bid||32.40 x 2200|
|Ask||36.20 x 1300|
|Day's Range||33.01 - 34.79|
|52 Week Range||24.58 - 43.39|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ShockWave Medical, Inc. (“ShockWave”) (SWAV), today announced the closing of its initial public offering of 6,555,000 shares of its common stock at an initial public offering price of $17.00 per share, including 855,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares. ShockWave’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol “SWAV”. Morgan Stanley and BofA Merrill Lynch acted as joint lead book-running managers for the offering.
"I feel like a kid in a candy store right now," CEO Doug Godshall told the Business Journal after his company's first day of trading on Wall Street. Here's what's next for Shockwave after its blockbuster debut on the Nasdaq.
Six fundings, six acquisition deals and another company getting set to go public highlight Bay Area venture news at the end of the week. Here's more of those and other founder and funder news from the region.